Abbott Laboratories EV/EBIT ABT

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2010.

Today, Oct 23, 2026: 28.2×
10-year median: 31.9×
Against its 10-year history: 28th; percentile: 0 is its lowest day, 100 its highest
10-year range: 17.0× to 82.9×
Peer median: 21.5×

Abbott Laboratories' EV/EBIT is 28.2× as of Oct 23, 2026.

That is below its ten-year median of 31.9×, lower than on 72% of days in the last ten years.

Over that time it ranged from 17.0× in Oct 2022 to 82.9× in Mar 2018.

The median for 7 medical device stocks of a similar size is 21.5×.

EV/EBIT over time

median 31.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	28.2×	20.2×	31.2×
2025	28.9×	28.6×	36.0×
2024	30.9×	29.2×	34.0×
2023	32.7×	20.3×	32.7×
2022	20.9×	17.0×	29.2×
2021	30.3×	26.9×	55.1×
2020	47.5×	29.2×	51.7×
2019	39.1×	37.2×	47.8×
2018	45.0×	42.8×	82.9×
2017	60.4×	20.9×	60.4×
2016	19.9×	19.6×	25.3×
2015	24.1×	20.2×	31.4×
2014	30.3×	20.2×	30.5×
2013	21.2×	15.8×	26.6×
2012	14.9×	8.7×	15.7×
2011	9.2×	7.3×	9.2×
2010	7.6×	7.5×	8.1×

Against its peers

Companies in Medical - Devices nearest Abbott Laboratories' size, closest first, today.

Company	EV/EBIT
ABTAbbott Laboratories	28.2×
MDTMedtronic	20.7×
SYKStryker	23.4×
BSXBoston Scientific	18.2×
EWEdwards Lifesciences	23.5×
GEHCGE HealthCare Technologies	14.7×
DXCMDexCom	25.3×
ZBHZimmer Biomet	21.5×
Peer median	21.5×

Where Abbott Laboratories ranks

#11of 13Medical device stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Abbott Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.